RSA of the ATTUNE Knee System: RCT Comparing Traditional Vs Enhanced-Fixation Device Designs

Sponsor
Canadian Radiostereometric Analysis Network (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03554720
Collaborator
Orthopaedic Innovation Centre (Other), Dalhousie University (Other), London Health Sciences Centre (Other)
50
2
2
52.9
25
0.5

Study Details

Study Description

Brief Summary

The principal objective of this study is to compare migration patterns between the Attune and Attune S+ PS knee systems using model-based RSA over the first 2 post-operative years. Secondary objectives include; comparison of 2-year migration values against published thresholds for adequate short-term fixation, quantify changes in functional and health status of subjects following surgery and compare between study groups, and assess occurrences of complications following surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: ATTUNE PS Knee
  • Device: ATTUNE S+ PS Knee
N/A

Detailed Description

This is a multi-centre, randomized controlled trial of patients undergoing posterior-stabilized total knee arthroplasty. In this study, the investigators propose to randomize 50 subjects to receive either the standard Attune PS TKA (n=25) or the enhanced fixation Attune S+ PS TKA (n=25) and follow them for a period of 2 years post-operatively. The primary outcome of the study will be stability of fixation of the tibial baseplate as measured by model-based RSA. Secondary outcomes will be to determine the functionality of patients after surgery using self-reported questionnaires.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Radiostereometric Analysis (RSA) of the ATTUNE Knee System: A Randomized Controlled Trial Comparing Traditional Versus Enhanced-Fixation Device Designs
Actual Study Start Date :
Jul 4, 2018
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard implants

ATTUNE PS Knee

Device: ATTUNE PS Knee
The ATTUNE PS Knee is the standard implants.

Active Comparator: Enhanced-Fixation

ATTUNE S+ PS Knee

Device: ATTUNE S+ PS Knee
The ATTUNE S+ PS Knee is the enhanced fixation.

Outcome Measures

Primary Outcome Measures

  1. RSA Migration [2 Years]

    Migration of the tibial and femoral components between the 2 device designs.

Secondary Outcome Measures

  1. Knee Replacement Expectation Survey (KRES) [Preoperative]

    The KRES is a patient reported questionnaire that consists of 19 questions. The questions ask how each expectation is important in the treatment of the knee. The scale is rated: 1 (Very important) to 5 (This does not apply to me). The score ranges from 19 to 95 with higher scores associated with higher expectations.

  2. European Quality of Life (EQ-5D-5L) [Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments. The EuroQol 5D 5L questionnaire is a standardized instrument for use as a measure of health outcome that is designed for completion by the subject.

  3. Pain score [Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable)

  4. Patient satisfaction [Preoperative, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied)

  5. Oxford 12 Knee [Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome

  6. University of California at Los Angeles (UCLA) Activity Level scale [Preoperative, 6 Months, 1 Year and 2 Years]]

    Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.

  7. Pain Catastrophizing Scale (PCS) [Preoperative and 1 Year]

    The patient are asked to indicate the degree to which they have the above thoughts and feelings when they are experiencing pain. Each PCS item is rated on a 5-point scale: 0 (not at all) to 4 (all the time). The PCS total score is computed by summing responses to the 13 items. PCS total scores range from 0 - 52.

  8. Pre-operative Patient's Knee Implant Performance (PKIP) [Preoperative, 6 Months, 1 Year and 2 Years]

    The Pre-surgical and/or Post-surgical Patient's Knee Implant Performance (PKIP) questionnaire is a patient reported questionnaire that consists of 24 questions relating to the patient's awareness of their knee. Questions include the patient's self-confidence about the current status of their knee performance, stability, and overall satisfaction. Each question has a 5, 6 or 10 Likaert- like response option.

  9. Patient complications [Preoperative, 1 Week, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years]

    Evaluate the type and frequency of the complications/adverse events.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty

  • Between the ages of 21 and 80 inclusive

  • Patients willing and able to comply with follow-up requirements and self-evaluations

  • Ability to give informed consent

Exclusion Criteria:
  • Active or prior infection

  • Medical condition precluding major surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Concordia Hospital Winnipeg Manitoba Canada R2K 3S8
2 London Health Sciences Centre London Ontario Canada N6A 5W9

Sponsors and Collaborators

  • Canadian Radiostereometric Analysis Network
  • Orthopaedic Innovation Centre
  • Dalhousie University
  • London Health Sciences Centre

Investigators

  • Principal Investigator: Thomas Turgeon, MD MPH FRCSC, University of Manitoba
  • Principal Investigator: Glen Richardson, MD MSc FRCSC, Dalhousie University
  • Principal Investigator: Douglas Naudie, MD FRCSC, London Health Sciences Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Canadian Radiostereometric Analysis Network
ClinicalTrials.gov Identifier:
NCT03554720
Other Study ID Numbers:
  • HS21601
First Posted:
Jun 13, 2018
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2022